Asia myelodysplastic syndrome registry study
Part of Blood & lymphatic clinical trials.
This study is a registry, meaning it collects information about people with Myelodysplastic Syndrome (MDS) to help doctors learn more about the condition. If you join, you simply allow your existing medical data to be used for research. It does not involve any new treatments or tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older at the time of your MDS diagnosis
- You have been diagnosed with MDS by a doctor
- Your diagnosis was made between January 2019 and December 2022, or between October 2025 and September 2026
- Your diagnosis was based on a bone marrow test (called an aspirate) done within 100 days of the diagnosis date
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information and blood samples from people with myelodysplastic syndrome (MDS) or related conditions over time. It aims to better understand these diseases and improve future care.
This study is a database that collects information from people diagnosed with myelodysplastic syndromes. It may help researchers better understand the condition and how patients do over time.
This study collects information from people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that developed after cancer treatment. It does not test a new drug but helps doctors learn more about these conditions.
This study is building a national platform in Spain to better understand MDS (a bone marrow disorder) and to help tailor treatments to each person. By joining, you help researchers learn more about your condition and how to manage it.
This study is a registry that collects information from people newly diagnosed with myelodysplastic syndrome (MDS). It helps researchers understand the condition better and may guide future studies.
This study carefully evaluates people with myelodysplastic syndromes (MDS) and closely related blood disorders using detailed medical, blood, and bone marrow testing. The goal is to better understand these conditions and how they progress, which may help guide future care.
Hear when a new Myelodysplastic Syndromes (MDS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.